Abstract |
Fosmidomycin is effective against malaria, but it needs to be given for > or =4 days when used alone. We conducted a study of 50 children with Plasmodium falciparum malaria to evaluate the safety and efficacy of consecutively shortened regimens of artesunate- fosmidomycin (1 to 2 mg/kg of body weight and 30 mg/kg of body weight, respectively; doses given every 12 hours). All dosing regimens were well tolerated. Artesunate- fosmidomycin acted rapidly, resulting in consolidated geometric mean parasite and fever clearance times of 24 h and 15 h, respectively. Treatment regimens of > or =2 days led to cure ratios of 100% by day 14 (39/39; 95% confidence interval [95% CI], 91% to 100%). Most importantly, the 3-day regimen achieved 100% cure on day 28 (10/10; 95% CI, 69% to 100%). Treatment with artesunate- fosmidomycin was associated with transient grade I or II neutropenia (absolute neutrophil counts of 750 to 1,200/microl and 400 to 749/microl, respectively) in six or two patients, respectively. Artesunate- fosmidomycin demonstrates the feasibility and potential value of short-course artemisinin-based combination chemotherapy with rapidly eliminated combination partners.
|
Authors | Steffen Borrmann, Ayola A Adegnika, Félicien Moussavou, Sunny Oyakhirome, Gilbert Esser, Pierre-Blaise Matsiegui, Michael Ramharter, Ingrid Lundgren, Maryvonne Kombila, Saadou Issifou, David Hutchinson, Jochen Wiesner, Hassan Jomaa, Peter G Kremsner |
Journal | Antimicrobial agents and chemotherapy
(Antimicrob Agents Chemother)
Vol. 49
Issue 9
Pg. 3749-54
(Sep 2005)
ISSN: 0066-4804 [Print] United States |
PMID | 16127049
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antimalarials
- Artemisinins
- Drug Combinations
- Sesquiterpenes
- Fosfomycin
- fosmidomycin
- Artesunate
|
Topics |
- Antimalarials
(adverse effects, therapeutic use)
- Artemisinins
(adverse effects, therapeutic use)
- Artesunate
- Chemistry, Pharmaceutical
- Child
- Cohort Studies
- Dose-Response Relationship, Drug
- Drug Combinations
- Endpoint Determination
- Female
- Fosfomycin
(adverse effects, analogs & derivatives, therapeutic use)
- Humans
- Malaria, Falciparum
(blood, drug therapy, parasitology)
- Male
- Reverse Transcriptase Polymerase Chain Reaction
- Sesquiterpenes
(adverse effects, therapeutic use)
|